methylprednisolone has been researched along with Depressive Disorder in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceanga, M; Chung, HY; Geis, C; Sell, J; Voss, A; Wickel, J; Witte, OW | 1 |
Du, M; Hu, ZB; Huang, F; Li, J; Muhtar, W; Shi, HL; Wang, TT; Wu, H; Wu, XJ; Yang, L; Zhang, BB | 1 |
Iacob, SA; Sotropa, A | 1 |
Heigl, B; Naber, D; Sand, P | 1 |
Benazzi, F | 1 |
Kuroda, S; Lee, Y; Suzuki, H; Wada, K; Yamada, N | 1 |
Nitzsche, W; Pötzsch, M; Schütt, C | 1 |
Soyka, M | 1 |
8 other study(ies) available for methylprednisolone and Depressive Disorder
Article | Year |
---|---|
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Topics: Administration, Intravenous; Autoantibodies; Cell Adhesion Molecules, Neuronal; Cognitive Dysfunction; Cyclophosphamide; Depressive Disorder; Dysarthria; Encephalitis; GABA-B Receptor Antagonists; Gait Disorders, Neurologic; Glucocorticoids; Hallucinations; Hashimoto Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Sleep Wake Disorders; Treatment Outcome | 2019 |
Simultaneous quantification of seven hippocampal neurotransmitters in depression mice by LC-MS/MS.
Topics: Animals; Chromatography, Liquid; Depressive Disorder; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Hydroxyindoleacetic Acid; Male; Methylprednisolone; Mice, Inbred C57BL; Neurotransmitter Agents; Norepinephrine; Regression Analysis; Sensitivity and Specificity; Serotonin; Tandem Mass Spectrometry | 2014 |
DRESS syndrome with hepatic involvement in a patient with depressive disorder.
Topics: Adult; Anti-Inflammatory Agents; Depressive Disorder; Drug Hypersensitivity Syndrome; Female; Humans; Liver Diseases; Methylprednisolone | 2014 |
Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluocortolone; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychiatric Status Rating Scales; Retinitis; Substance-Related Disorders; Uveitis | 1996 |
Resistant depression associated with lupus erythematosus and steroid therapy.
Topics: Aged; Antidepressive Agents; Dementia, Multi-Infarct; Depressive Disorder; Diagnosis, Differential; Drug Resistance; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neurocognitive Disorders; Psychoses, Substance-Induced | 1997 |
Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Male; Methylprednisolone; Middle Aged; Mood Disorders; Psychiatry; Pulse Therapy, Drug; Recurrence; Referral and Consultation | 2000 |
[Results of a study of glucocorticoid receptors in lymphocytes of patients with endogenous depression].
Topics: Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Lymphocyte Activation; Methylprednisolone; Receptors, Glucocorticoid | 1990 |
[Recurrent confusional states in the cerebral manifestations of Behçet's disease. A case report with an 11-year follow-up].
Topics: Behcet Syndrome; Cognition Disorders; Confusion; Depressive Disorder; Encephalitis; Female; Follow-Up Studies; Humans; Methylprednisolone; Middle Aged | 1987 |